​

Elanco Animal Health (ELAN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ELAN Stock Forecast

Elanco Animal Health (ELAN) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $27.88, with a high of $30.00 and a low of $22.00. This represents a 18.89% increase from the last price of $23.45.

$10 $14 $18 $22 $26 $30 High: $30 Avg: $27.88 Low: $22 Last Closed Price: $23.45

ELAN Stock Rating

Elanco Animal Health stock's rating consensus is Buy, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (70.00%), 4 Hold (20.00%), 2 Sell (10.00%), and 0 Strong Sell (0.00%).

Buy
Total 20 0 2 4 14 Strong Sell Sell Hold Buy Strong Buy

ELAN Price Target Upside V Benchmarks

TypeNameUpside
StockElanco Animal Health18.89%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks22.70%

Price Target Trends

1M3M12M
# Anlaysts2515
Avg Price Target$29.50$28.20$24.60
Last Closing Price$23.45$23.45$23.45
Upside/Downside25.80%20.26%4.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 264102-117
Feb, 26493-117
Jan, 263103-117
Dec, 252103-116
Nov, 25284-115
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 25, 2026Steve DechertKeyBanc$29.00$27.136.89%23.67%
Feb 24, 2026Daniel ClarkLeerink Partners$30.00$26.3713.77%27.93%
Jan 29, 2026UBS$30.00$24.1724.12%27.93%
Jan 22, 2026David WestenbergPiper Sandler$30.00$24.3023.46%27.93%
Dec 18, 2025Morgan Stanley$22.00$22.08-0.36%-6.18%
Dec 08, 2025Barclays$30.00$21.6938.31%27.93%
Nov 20, 2025KeyBanc$27.00$21.4625.82%15.14%
Nov 19, 2025Argus Research$25.00$21.4616.50%6.61%
Nov 05, 2025Stifel Nicolaus$27.00$21.9123.23%15.14%
Oct 20, 2025UBS$25.00$21.6415.53%6.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 10, 2026UBSBuyBuyhold
Feb 25, 2026KeyBancOverweightOverweighthold
Jan 29, 2026UBSBuyBuyhold
Jan 22, 2026Piper SandlerNeutralOverweightupgrade
Dec 18, 2025Morgan StanleyUnderperformUnderperformhold
Dec 10, 2025KeyBancOverweightOverweighthold
Dec 08, 2025BarclaysOverweightOverweightinitialise
Nov 20, 2025KeyBancOverweightinitialise
Oct 20, 2025UBSBuyBuyhold
Aug 11, 2025Piper SandlerNeutralNeutralhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.97$-0.15$-2.50$0.68$-0.47---
Avg Forecast$1.01$1.04$0.92$0.91$0.90$1.05$1.22$1.44
High Forecast$1.02$1.06$0.95$0.92$0.99$2.32$1.49$1.47
Low Forecast$0.99$1.03$0.91$0.90$0.82$0.28$0.86$1.42
Surprise %-196.04%-114.42%-371.74%-25.27%-152.22%---

Revenue Forecast

$4B $4B $5B $5B $5B $6B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.76B$4.41B$4.42B$4.44B$4.71B---
Avg Forecast$4.75B$4.41B$4.39B$4.42B$4.54B$4.75B$5.03B$5.28B
High Forecast$4.79B$4.45B$4.40B$4.44B$4.57B$4.75B$5.04B$5.36B
Low Forecast$4.70B$4.38B$4.38B$4.34B$4.49B$4.75B$5.01B$5.23B
Surprise %0.19%0.03%0.72%0.35%3.82%---

Net Income Forecast

$-2B $-1B $-600M $100M $800M $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-483.00M$-78.00M$-1.23B$338.00M$-232.00M---
Avg Forecast$-378.78M$-141.47M$-1.23B$450.17M$445.93M$639.60M$578.20M$710.55M
High Forecast$-303.02M$-94.52M$-822.50M$455.07M$487.35M$1.14B$732.39M$722.92M
Low Forecast$-454.53M$-188.41M$-1.64B$445.28M$404.50M$137.76M$424.01M$700.70M
Surprise %27.51%-44.86%--24.92%-152.03%---

ELAN Forecast FAQ

Is Elanco Animal Health stock a buy?

Elanco Animal Health stock has a consensus rating of Buy, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 4 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Elanco Animal Health is a favorable investment for most analysts.

What is Elanco Animal Health's price target?

Elanco Animal Health's price target, set by 20 Wall Street analysts, averages $27.88 over the next 12 months. The price target range spans from $22 at the low end to $30 at the high end, suggesting a potential 18.89% change from the previous closing price of $23.45.

How does Elanco Animal Health stock forecast compare to its benchmarks?

Elanco Animal Health's stock forecast shows a 18.89% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (22.70%).

What is the breakdown of analyst ratings for Elanco Animal Health over the past three months?

  • March 2026: 23.53% Strong Buy, 58.82% Buy, 11.76% Hold, 0% Sell, 5.88% Strong Sell.
  • February 2026: 23.53% Strong Buy, 52.94% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.
  • January 2026: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.

What is Elanco Animal Health’s EPS forecast?

Elanco Animal Health's average annual EPS forecast for its fiscal year ending in December 2026 is $1.05, marking a -323.40% decrease from the reported $-0.47 in 2025. Estimates for the following years are $1.22 in 2027, and $1.44 in 2028.

What is Elanco Animal Health’s revenue forecast?

Elanco Animal Health's average annual revenue forecast for its fiscal year ending in December 2026 is $4.75B, reflecting a 0.79% increase from the reported $4.72B in 2025. The forecast for 2027 is $5.03B, and $5.28B for 2028.

What is Elanco Animal Health’s net income forecast?

Elanco Animal Health's net income forecast for the fiscal year ending in December 2026 stands at $639.6M, representing a -375.69% decrease from the reported $-232M in 2025. Projections indicate $578.2M in 2027, and $710.55M in 2028.